Get Up to $200 Towards Your Copay!

You may be eligible to receive up to $200 towards your non-reimbursable
copay expenses for iLink FDA-approved cross-linking procedure.

Keratoconus Journeys

“Baseball has been a part of my DNA since I could pick up a bat. This surgery…has given me kind of a second chance at being able to do things at a level I never thought I would be able to do.”
– Chris H., broadcaster for the Mississippi Braves

What is keratoconus?

Commonly known as ‘KC’, keratoconus can result in significant visual impairment.

What is cross-linking?

Corneal cross-linking is a minimally invasive outpatient procedure used to treat progressive keratoconus.

Limits Progression of Keratoconus

FDA Approved

Insurance Reimbursement

The iLink cross-linking procedure is the first and only therapeutic treatment that stiffens the cornea to slow the progression of keratoconus.

What is

Keratoconus?

Keratoconus is a progressive eye disease in which the normally round cornea thins and begins to bulge into a cone-like shape, causing distorted vision.

Learn about Insurance Coverage

What is Cross-Linking?

Corneal collagen cross-linking is a minimaly invasive outpatient procedure to slow or halt the progression of keratoconus.

Is Cross-Linking
Right for Me?

If you are suffering from keratoconus, corneal cross-linking may be right for you.

Want to See the Difference?

"Corneal cross-linking provides patients a much-needed option. totreat this debilitating disease. Patients suffering from progressive keratoconus can now receive a therapeutic treatment that has been rigorously tested and approved."

 

Mary Prudden, Executive Director for the National Keratoconus Foundation

"Keratoconus, when left untreated, can result in significat deterioration of vision, and may lead to multiple corneal transplants, with the potential to adversely affect patients' quality of life."

 

Rajesh Rajpal, MD, See Clearly Vision, McLean, VA

Find a Cross-Linking Expert Near You

MA-00685E